Anat Biegon

Summary

Affiliation: Brookhaven National Laboratory
Country: USA

Publications

  1. ncbi Unique distribution of aromatase in the human brain: in vivo studies with PET and [N-methyl-11C]vorozole
    Anat Biegon
    Medical Department, Brookhaven National Laboratory, Upton, New York 11973, USA
    Synapse 64:801-7. 2010
  2. ncbi Nicotine blocks brain estrogen synthase (aromatase): in vivo positron emission tomography studies in female baboons
    Anat Biegon
    Brookhaven National Laboratory, Upton, New York, USA
    Biol Psychiatry 67:774-7. 2010
  3. ncbi Dynamic changes in N-methyl-D-aspartate receptors after closed head injury in mice: Implications for treatment of neurological and cognitive deficits
    Anat Biegon
    Department of Functional Imaging, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
    Proc Natl Acad Sci U S A 101:5117-22. 2004
  4. ncbi In vitro and in vivo characterization of [3H]CNS-5161--a use-dependent ligand for the N-methyl-D-aspartate receptor in rat brain
    Anat Biegon
    Medical Department, Brookhaven National Laboratory, Upton, New York, USA
    Synapse 61:577-86. 2007
  5. ncbi Cannabinoids as neuroprotective agents in traumatic brain injury
    Anat Biegon
    Department Functional Imaging, Lawrence Berkeley National Laboratory, Berkeley, CA, USA
    Curr Pharm Des 10:2177-83. 2004
  6. ncbi Gene x disease interaction on orbitofrontal gray matter in cocaine addiction
    Nelly Alia-Klein
    Medical Department, Brookhaven National Laboratory, Upton, NY 11973 5000, USA
    Arch Gen Psychiatry 68:283-94. 2011
  7. ncbi Synthesis and PET studies of [(11)C-cyano]letrozole (Femara), an aromatase inhibitor drug
    Kun Eek Kil
    Medical Department, Brookhaven National Laboratory, Upton, NY 11973, USA
    Nucl Med Biol 36:215-23. 2009
  8. ncbi Reinvestigation of the synthesis and evaluation of [N-methyl-(11)C]vorozole, a radiotracer targeting cytochrome P450 aromatase
    Sung Won Kim
    Medical Department, Brookhaven National Laboratory, Upton, NY 11973, USA
    Nucl Med Biol 36:323-34. 2009
  9. ncbi Neural mechanisms of anger regulation as a function of genetic risk for violence
    Nelly Alia-Klein
    Medical Department, Brookhaven National Laboratory, Upton, NY 11973 5000, USA
    Emotion 9:385-96. 2009
  10. ncbi Modeling and analysis of PET studies with norepinephrine transporter ligands: the search for a reference region
    Jean Logan
    Chemistry Department, Brookhaven National Laboratory, Upton, NY 11973, USA
    Nucl Med Biol 32:531-42. 2005

Research Grants

  1. NMDA Receptor Dynamics After Brain Injury
    Anat Biegon; Fiscal Year: 2007
  2. NMDA Receptor Dynamics After Brain Injury
    Anat Biegon; Fiscal Year: 2009
  3. NMDA Receptor Dynamics After Brain Injury
    Anat Biegon; Fiscal Year: 2011

Collaborators

Detail Information

Publications23

  1. ncbi Unique distribution of aromatase in the human brain: in vivo studies with PET and [N-methyl-11C]vorozole
    Anat Biegon
    Medical Department, Brookhaven National Laboratory, Upton, New York 11973, USA
    Synapse 64:801-7. 2010
    ..These studies set the stage for the noninvasive assessment of aromatase involvement in various physiological and pathological processes affecting the human brain...
  2. ncbi Nicotine blocks brain estrogen synthase (aromatase): in vivo positron emission tomography studies in female baboons
    Anat Biegon
    Brookhaven National Laboratory, Upton, New York, USA
    Biol Psychiatry 67:774-7. 2010
    ..We report the first in vivo primate study to determine whether there is a direct effect of nicotine administration on brain aromatase...
  3. ncbi Dynamic changes in N-methyl-D-aspartate receptors after closed head injury in mice: Implications for treatment of neurological and cognitive deficits
    Anat Biegon
    Department of Functional Imaging, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
    Proc Natl Acad Sci U S A 101:5117-22. 2004
    ....
  4. ncbi In vitro and in vivo characterization of [3H]CNS-5161--a use-dependent ligand for the N-methyl-D-aspartate receptor in rat brain
    Anat Biegon
    Medical Department, Brookhaven National Laboratory, Upton, New York, USA
    Synapse 61:577-86. 2007
    ..Thus, CNS-5161 binds preferentially to the activated state of the NMDA receptor channel in vitro and in vivo. The high affinity and fast kinetics make it compatible with PET imaging of a carbon-11 labeled CNS-5161...
  5. ncbi Cannabinoids as neuroprotective agents in traumatic brain injury
    Anat Biegon
    Department Functional Imaging, Lawrence Berkeley National Laboratory, Berkeley, CA, USA
    Curr Pharm Des 10:2177-83. 2004
    ....
  6. ncbi Gene x disease interaction on orbitofrontal gray matter in cocaine addiction
    Nelly Alia-Klein
    Medical Department, Brookhaven National Laboratory, Upton, NY 11973 5000, USA
    Arch Gen Psychiatry 68:283-94. 2011
    ..However, the concomitant use of other drugs and common genetic variability in monoamine regulation present additional structural variability...
  7. ncbi Synthesis and PET studies of [(11)C-cyano]letrozole (Femara), an aromatase inhibitor drug
    Kun Eek Kil
    Medical Department, Brookhaven National Laboratory, Upton, NY 11973, USA
    Nucl Med Biol 36:215-23. 2009
    ..5 nM) that has Food and Drug Administration approval for breast cancer treatment. Here we report the synthesis of carbon-11-labeled letrozole and its assessment as a radiotracer for brain aromatase in the baboon...
  8. ncbi Reinvestigation of the synthesis and evaluation of [N-methyl-(11)C]vorozole, a radiotracer targeting cytochrome P450 aromatase
    Sung Won Kim
    Medical Department, Brookhaven National Laboratory, Upton, NY 11973, USA
    Nucl Med Biol 36:323-34. 2009
    ..Herein we report the preparation and positron emission tomography (PET) studies of pure [N-methyl-(11)C]vorozole...
  9. ncbi Neural mechanisms of anger regulation as a function of genetic risk for violence
    Nelly Alia-Klein
    Medical Department, Brookhaven National Laboratory, Upton, NY 11973 5000, USA
    Emotion 9:385-96. 2009
    ....
  10. ncbi Modeling and analysis of PET studies with norepinephrine transporter ligands: the search for a reference region
    Jean Logan
    Chemistry Department, Brookhaven National Laboratory, Upton, NY 11973, USA
    Nucl Med Biol 32:531-42. 2005
    ..The focus of this work is to identify a suitable reference region or means of normalizing data for the NET ligands investigated...
  11. ncbi Maternal and fetal 11C-cocaine uptake and kinetics measured in vivo by combined PET and MRI in pregnant nonhuman primates
    Helene Benveniste
    Medical Department, Brookhaven National Laboratory, Upton, New York 11793, USA
    J Nucl Med 46:312-20. 2005
    ..Here, we evaluate the utility of PET to measure the uptake and distribution of (11)C-cocaine in the third-trimester fetus...
  12. ncbi Brain monoamine oxidase A activity predicts trait aggression
    Nelly Alia-Klein
    Medical Department, Brookhaven National Laboratory, Upton, New York 11973, USA
    J Neurosci 28:5099-104. 2008
    ..Because trait aggression is a measure used to predict antisocial behavior, these results underscore the relevance of MAO A as a neurochemical substrate of aberrant aggression...
  13. ncbi Evidence of gender differences in the ability to inhibit brain activation elicited by food stimulation
    Gene Jack Wang
    Medical Department, Brookhaven National Laboratory, Upton, NY, 11973, USA
    Proc Natl Acad Sci U S A 106:1249-54. 2009
    ..This finding suggests a mechanism by which cognitive inhibition decreases the desire for food and implicates lower ability to suppress hunger in women as a contributing factor to gender differences in obesity...
  14. ncbi Serial microPET measures of the metabolic reaction to a microdialysis probe implant
    Wynne K Schiffer
    Graduate Program in Neuroscience, Department of Neurobiology and Behavior, Stony Brook University, Stony Brook, NY 11794 5230, USA
    J Neurosci Methods 155:272-84. 2006
    ..Despite the extent and persistence of these reductions, 11C-raclopride binding and ECF DA concentrations remained stable...
  15. ncbi 6-[18F]Fluoro-A-85380, a new PET tracer for the nicotinic acetylcholine receptor: studies in the human brain and in vivo demonstration of specific binding in white matter
    Yu-Shin Ding
    Chemistry Department, Brookhaven National Laboratory, Upton, New York 11973, USA
    Synapse 53:184-9. 2004
  16. ncbi Transient focal ischemia results in persistent and widespread neuroinflammation and loss of glutamate NMDA receptors
    Jasbeer Dhawan
    Medical Department, Brookhaven National Laboratory, Building 490, Upton, NY 11973, USA
    Neuroimage 51:599-605. 2010
    ..Persistent, bilateral loss of NMDAR, probably reflecting receptor down regulation and internalization, may be responsible for some of the effects of stroke on cognitive function which cannot be explained by infarction alone...
  17. ncbi D-cycloserine improves functional recovery and reinstates long-term potentiation (LTP) in a mouse model of closed head injury
    Rami Yaka
    Department of Pharmacology, School of Pharmacy, The Hebrew University of Jerusalem, POB 12065, Jerusalem 91120, Israel
    FASEB J 21:2033-41. 2007
    ..Since DCS is in clinical use for other indications, the present study offers a novel approach to treat human brain injury...
  18. ncbi Metabolic and behavioral deficits following a routine surgical procedure in rats
    David B Frumberg
    Cornell University, Ithaca NY 14853, USA
    Brain Res 1144:209-18. 2007
    ..Probe implantation in the striatum results in a widespread and long-lasting decline in cortical glucose metabolism together with a persistent, injury-related deficit in the performance of a cognitive (object recognition) task in rats...
  19. ncbi The Ras inhibitor S-trans, trans-farnesylthiosalicylic acid exerts long-lasting neuroprotection in a mouse closed head injury model
    Esther Shohami
    Department of Pharmacology, School of Pharmacy, Hadassah Medical Center, The Hebrew University, Jerusalem, Israel
    J Cereb Blood Flow Metab 23:728-38. 2003
    ..These findings suggest that nontoxic Ras inhibitors such as FTS may qualify as neuroprotective drugs...
  20. ncbi Dexanabinol (HU-211) in the treatment of severe closed head injury: a randomized, placebo-controlled, phase II clinical trial
    Nachshon Knoller
    Department of Neurosurgery, Sheba Medical Center, Tel-Hashomer, Israel
    Crit Care Med 30:548-54. 2002
    ..The treated patients achieved significantly better intracranial pressure/cerebral perfusion pressure control without jeopardizing blood pressure. A trend toward faster and better neurologic outcome was also observed...
  21. ncbi Inhibition of NR2B phosphorylation restores alterations in NMDA receptor expression and improves functional recovery following traumatic brain injury in mice
    Johanna Schumann
    Department of Pharmacology, School of Pharmacy, Hebrew University of Jerusalem, Jerusalem, Israel
    J Neurotrauma 25:945-57. 2008
    ....
  22. ncbi Sex-related differences in patients with severe head injury: greater susceptibility to brain swelling in female patients 50 years of age and younger
    Azadeh Farin
    Department of Family and Preventive Medicine, University of California School of Medicine, San Diego, La Jolla, California 92037, USA
    J Neurosurg 98:32-6. 2003
    ....
  23. ncbi Clinical trials in head injury
    Raj K Narayan
    Department of Neurosurgery, Temple University Hospital, Philadelphia, Pennsylvania 19140, USA
    J Neurotrauma 19:503-57. 2002
    ..This paper is an attempt to summarize the key points made at the workshop. It is hoped that these lessons will enhance the planning and design of future efforts in this important field of research...

Research Grants5

  1. NMDA Receptor Dynamics After Brain Injury
    Anat Biegon; Fiscal Year: 2007
    ..The results may explain the failure of NMDAR antagonists in clinical trials and suggest novel strategies for treatment of brain injury. ..
  2. NMDA Receptor Dynamics After Brain Injury
    Anat Biegon; Fiscal Year: 2009
    ..The results may explain the failure of NMDAR antagonists in clinical trials and suggest novel strategies for treatment of brain injury. ..
  3. NMDA Receptor Dynamics After Brain Injury
    Anat Biegon; Fiscal Year: 2011
    ..The results may explain the failure of NMDAR antagonists in clinical trials and suggest novel strategies for treatment of brain injury. ..